A World Health Organization (WHO) Feb 2018 report has recently shown that mortality rate due to brain or central nervous system (CNS) cancer is the highest in the Asian continent. It is of critical ...importance that cancer be detected earlier so that many of these lives can be saved. Cancer grading is an important aspect for targeted therapy. As cancer diagnosis is highly invasive, time consuming and expensive, there is an immediate requirement to develop a non-invasive, cost-effective and efficient tools for brain cancer characterization and grade estimation. Brain scans using magnetic resonance imaging (MRI), computed tomography (CT), as well as other imaging modalities, are fast and safer methods for tumor detection. In this paper, we tried to summarize the pathophysiology of brain cancer, imaging modalities of brain cancer and automatic computer assisted methods for brain cancer characterization in a machine and deep learning paradigm. Another objective of this paper is to find the current issues in existing engineering methods and also project a future paradigm. Further, we have highlighted the relationship between brain cancer and other brain disorders like stroke, Alzheimer's, Parkinson's, and Wilson's disease, leukoriaosis, and other neurological disorders in the context of machine learning and the deep learning paradigm.
•Introduce Gaussian process classification (GPC) technique for diabetes classification in machine learning framework.•GPC uses three kernels types, namely: linear, polynomial and radial basis ...kernel.•Comparison of GPC with existing classification techniques such as: LDA, QDA and NB.•GPC-based model gave highest accuracy, sensitivity, specificity and other performance parameters.•Machine learning systems are very useful for Diabetes data classification, one of the deadly diseases of the globe.
Diabetes is a silent killer. The main cause of this disease is the presence of excessive amounts of metabolites such as glucose. There were about 387 million diabetic people all over the world in 2014. The financial burden of this disease has been calculated to be about $13,700 per year. According to the World Health Organization (WHO), these figures will more than double by the year 2030. This cost will be reduced dramatically if someone can predict diabetes statistically on the basis of some covariates. Although several classification techniques are available, it is very difficult to classify diabetes. The main objectives of this paper are as follows: (i) Gaussian process classification (GPC), (ii) comparative classifier for diabetes data classification, (iii) data analysis using the cross-validation approach, (iv) interpretation of the data analysis and (v) benchmarking our method against others.
To classify diabetes, several classification techniques are used such as linear discriminant analysis (LDA), quadratic discriminant analysis (QDA), and Naive Bayes (NB). However, most of the medical data show non-normality, non-linearity and inherent correlation structure. So in this paper we adapted Gaussian process (GP)-based classification technique using three kernels namely: linear, polynomial and radial basis kernel. We also investigate the performance of a GP-based classification technique in comparison to existing techniques such as LDA, QDA and NB. Performances are evaluated by using the accuracy (ACC), sensitivity (SE), specificity (SP), positive predictive value (PPV), negative predictive value (NPV) and receiver-operating characteristic (ROC) curves.
Pima Indian diabetes dataset is taken as part of the study. This consists of 768 patients, of which 268 patients are diabetic and 500 patients are controls. Our machine learning system shows the performance of GP-based model as: ACC 81.97%, SE 91.79%, SP 63.33%, PPV 84.91% and NPV 62.50% which are larger compared to other methods.
Diabetes mellitus is a group of metabolic diseases in which blood sugar levels are too high. About 8.8% of the world was diabetic in 2017. It is projected that this will reach nearly 10% by 2045. The ...major challenge is that when machine learning-based classifiers are applied to such data sets for risk stratification, leads to lower performance. Thus, our objective is to develop an optimized and robust machine learning (ML) system under the assumption that missing values or outliers if replaced by a median configuration will yield higher risk stratification accuracy. This ML-based risk stratification is designed, optimized and evaluated, where: (i) the features are extracted and optimized from the six feature selection techniques (random forest, logistic regression, mutual information, principal component analysis, analysis of variance, and Fisher discriminant ratio) and combined with ten different types of classifiers (linear discriminant analysis, quadratic discriminant analysis, naïve Bayes, Gaussian process classification, support vector machine, artificial neural network, Adaboost, logistic regression, decision tree, and random forest) under the hypothesis that both missing values and outliers when replaced by computed medians will improve the risk stratification accuracy. Pima Indian diabetic dataset (768 patients: 268 diabetic and 500 controls) was used. Our results demonstrate that on replacing the missing values and outliers by group median and median values, respectively and further using the combination of random forest feature selection and random forest classification technique yields an accuracy, sensitivity, specificity, positive predictive value, negative predictive value and area under the curve as:
92.26%, 95.96%, 79.72%, 91.14%, 91.20%,
and
0.93
, respectively. This is an improvement of 10% over previously developed techniques published in literature. The system was validated for its stability and reliability. RF-based model showed the best performance when outliers are replaced by median values.
•Deep Learning (DL) technique is applied for detection of hypoechoic FLD and stratification of normal and abnormal US liver images under the class of Symtosis.•This paper provides comprehensive ...analysis and comparison of three ML-based classification methodologies: namely, support vector machines, extreme learning machines and deep learning.•A specialized deep learning operation called inception is comprehensively investigated.
Fatty Liver Disease (FLD) - a disease caused by deposition of fat in liver cells, is predecessor to terminal diseases such as liver cancer. The machine learning (ML) techniques applied for FLD detection and risk stratification using ultrasound (US) have limitations in computing tissue characterization features, thereby limiting the accuracy.
Under the class of Symtosis for FLD detection and risk stratification, this study presents a Deep Learning (DL)-based paradigm that computes nearly seven million weights per image when passed through a 22 layered neural network during the cross-validation (training and testing) paradigm. The DL architecture consists of cascaded layers of operations such as: convolution, pooling, rectified linear unit, dropout and a special block called inception model that provides speed and efficiency. All data analysis is performed in optimized tissue region, obtained by removing background information. We benchmark the DL system against the conventional ML protocols: support vector machine (SVM) and extreme learning machine (ELM).
The liver US data consists of 63 patients (27 normal/36 abnormal). Using the K10 cross-validation protocol (90% training and 10% testing), the detection and risk stratification accuracies are: 82%, 92% and 100% for SVM, ELM and DL systems, respectively. The corresponding area under the curve is: 0.79, 0.92 and 1.0, respectively. We further validate our DL system using two class biometric facial data that yields an accuracy of 99%.
DL system shows a superior performance for liver detection and risk stratification compared to conventional machine learning systems: SVM and ELM.
•Identification of high risk differential gene expression using statistical tests.•Development of a machine learning strategy for predicting the cancerous genes.•Four statistical tests and ten ...machine learning classifiers were experimentally preformed, validated and compared.
A colon microarray data is a repository of thousands of gene expressions with different strengths for each cancer cell. It is necessary to detect which genes are responsible for cancer growth. This study presents an exhaustive comparative study of different machine learning (ML) systems which serves two major purposes: (a) identification of high risk differential genes using statistical tests and (b) development of a ML strategy for predicting cancer genes.
Four statistical tests namely: Wilcoxon sign rank sum (WCSRS), t test, Kruskal–Wallis (KW), and F-test were adapted for cancerous gene identification using their p-values. The extracted gene set was used to classify cancer patients using ten classifiers namely: linear discriminant analysis (LDA), quadratic discriminant analysis (QDA), naïve Bayes (NB), Gaussian process classification (GPC), support vector machine (SVM), artificial neural network (ANN), logistic regression (LR), decision tree (DT), Adaboost (AB), and random forest (RF). Performance was then evaluated using cross-validation protocols and standardized metrics viz. accuracy (ACC) and area under the curve (AUC).
The colon cancer dataset consists of 2000 genes from 62 patients (40 cancer vs. 22 control). The overall mean ACC of our ML system using all four statistical tests and all ten classifiers was 90.50%. The ML system showed an ACC of 99.81% using a combination WCSRS test and RF-based classifier. This is an improvement of 8% over previously published values in literature.
RF-based model with statistical tests for detection of high risk genes showed the best performance for accurate cancer classification in multi-center clinical trials.
The launch of high-resolution remote sensing satellites like TerraSAR-X, WorldView, and Ikonos has benefited the combined application of synthetic aperture radar (SAR) and optical imageries ...tremendously. Specifically, in case of natural calamities or disasters, decision makers can now easily use an old archived optical with a newly acquired (postdisaster) SAR image. Although the latest satellites provide the end user already georeferenced and orthorectified data products, still, registration differences exist between different data sets. These differences need to be taken care of through quick automated registration techniques before using the images in different applications. Specifically, mutual information (MI) has been utilized for the intricate SAR-optical registration problem. The computation of this metric involves estimating the joint histogram directly from image intensity values, which might have been generated from different sensor geometries and/or modalities (e.g., SAR and optical). Satellites carrying high-resolution remote sensing sensors like TerraSAR-X and Ikonos generate enormous data volume along with fine Earth observation details that might lead to failure of MI to detect correct registration parameters. In this paper, a solely histogram-based method to achieve automatic registration within TerraSAR-X and Ikonos images acquired specifically over urban areas is analyzed. Taking future sensors into a perspective, techniques like compression and segmentation for handling the enormous data volume and incompatible radiometry generated due to different SAR-optical image acquisition characteristics have been rightfully analyzed. The findings indicate that the proposed method is successful in estimating large global shifts followed by a fine refinement of registration parameters for high-resolution images acquired over dense urban areas.
Cerebral small vessel disease (cSVD) has a crucial role in lacunar stroke and brain hemorrhages and is a leading cause of cognitive decline and functional loss in elderly patients. Based on ...underlying pathophysiology, cSVD can be subdivided into amyloidal and non-amyloidal subtypes. Genetic factors of cSVD play a pivotal role in terms of unraveling molecular mechanism. An important pathophysiological mechanism of cSVD is blood-brain barrier leakage and endothelium dysfunction which gives a clue in identification of the disease through circulating biological markers. Detection of cSVD is routinely carried out by key neuroimaging markers including white matter hyperintensities, lacunes, small subcortical infarcts, perivascular spaces, cerebral microbleeds, and brain atrophy. Application of neural networking, machine learning and deep learning in image processing have increased significantly for correct severity of cSVD. A linkage between cSVD and other neurological disorder, such as Alzheimer's and Parkinson's disease and non-cerebral disease, has also been investigated recently. This review draws a broad picture of cSVD, aiming to inculcate new insights into its pathogenesis and biomarkers. It also focuses on the role of deep machine strategies and other dimensions of cSVD by linking it with several cerebral and non-cerebral diseases as well as recent advances in the field to achieve sensitive detection, effective prevention and disease management.
•This review focuses different aspects of deep learning applications in radiology.•This paper covers evolution of deep learning, its potentials, risk and safety issues.•This review covers some deep ...learning techniques already applied.•It gives an overall view of impact of deep learning in the medical imaging industry.
The advent of Deep Learning (DL) is poised to dramatically change the delivery of healthcare in the near future. Not only has DL profoundly affected the healthcare industry it has also influenced global businesses. Within a span of very few years, advances such as self-driving cars, robots performing jobs that are hazardous to human, and chat bots talking with human operators have proved that DL has already made large impact on our lives. The open source nature of DL and decreasing prices of computer hardware will further propel such changes. In healthcare, the potential is immense due to the need to automate the processes and evolve error free paradigms. The sheer quantum of DL publications in healthcare has surpassed other domains growing at a very fast pace, particular in radiology. It is therefore imperative for the radiologists to learn about DL and how it differs from other approaches of Artificial Intelligence (AI). The next generation of radiology will see a significant role of DL and will likely serve as the base for augmented radiology (AR). Better clinical judgement by AR will help in improving the quality of life and help in life saving decisions, while lowering healthcare costs.
A comprehensive review of DL as well as its implications upon the healthcare is presented in this review. We had analysed 150 articles of DL in healthcare domain from PubMed, Google Scholar, and IEEE EXPLORE focused in medical imagery only. We have further examined the ethic, moral and legal issues surrounding the use of DL in medical imaging.
Deep learning (DL) is affecting each and every sphere of public and private lives and becoming a tool for daily use. The power of DL lies in the fact that it tries to imitate the activities of ...neurons in the neocortex of human brain where the thought process takes place. Therefore, like the brain, it tries to learn and recognize patterns in the form of digital images. This power is built on the depth of many layers of computing neurons backed by high power processors and graphics processing units (GPUs) easily available today. In the current scenario, we have provided detailed survey of various types of DL systems available today, and specifically, we have concentrated our efforts on current applications of DL in medical imaging. We have also focused our efforts on explaining the readers the rapid transition of technology from machine learning to DL and have tried our best in reasoning this paradigm shift. Further, a detailed analysis of complexities involved in this shift and possible benefits accrued by the users and developers.
Inflammatory bowel disease biomarkers Liu, Dandan; Saikam, Varma; Skrada, Katie A. ...
Medicinal research reviews,
September 2022, Volume:
42, Issue:
5
Journal Article
Peer reviewed
Open access
Inflammatory bowel disease (IBD) is characterized as chronic inflammation in the gastrointestinal tract, which includes two main subtypes, Crohn's disease and ulcerative colitis. Endoscopy combined ...with biopsy is the most effective way to establish IBD diagnosis and disease management. Imaging techniques have also been developed to monitor IBD. Although effective, the methods are expensive and invasive, which leads to pain and discomfort. Alternative noninvasive biomarkers are being explored as tools for IBD prognosis and disease management. This review focuses on novel biomarkers that have emerged in recent years. These serological biomarkers and microRNAs could potentially be used for disease management in IBD, thereby decreasing patient discomfort and morbidity.
PDF
